THE APEX TIMES
Chrissy Metz responds to online weight-loss critics, cites family experience and GLP-1 treatment
In a new interview, the “This Is Us” actress says she understands why people comment on public figures’ bodies, but argues that critics rarely engage with the health realities behind weight-loss decisions.
Chrissy Metz pushed back on online weight-loss critics on Monday, saying that people who question her body or her choices are “always going to have something to say.” Metz, who has spoken publicly in the past about her weight and medical journey, framed the criticism as part of a broader pattern of commentary directed at women and celebrities, even when the subject is health.
In the remarks reported by Fox News, Metz tied her own approach to the experience of losing her father to complications related to obesity. She said that personal history shaped how she thinks about weight, treatment, and what critics may not understand about health conditions that are not solely driven by willpower or lifestyle alone.
Metz said she began using GLP-1 medication after her father’s death, according to the Fox News account. She did not present the decision as a trend or a lifestyle shortcut, but rather as a response to medical realities and family circumstances that influenced her to seek a clinical option.
The actress’ comments come as GLP-1 drugs such as semaglutide and tirzepatide remain widely discussed in entertainment and online communities, with ongoing public debate about access, stigma, and how health decisions are communicated. Metz’s remarks add a personal perspective from a prominent actress who has used interviews to address body image and health, while also criticizing the certainty that online commentators often apply to other people’s bodies.
Metz also used the interview to address the nature of internet scrutiny, describing critics as persistent even when the public figure has offered context for her decisions. “There’s always going to have something to say,” she said in the Fox News report, portraying the criticism as difficult to avoid and not always grounded in understanding of health, treatment, or outcomes.
The remarks place Metz again at the center of a recurring culture conversation about how public figures discuss weight and medical care. For audiences, the controversy typically centers less on medical specifics than on whether discussing treatment is seen as empowering or reinforcing stigma, and on the question of who gets to define what counts as acceptable or credible health information.
While Metz’s statements underscore a family and health rationale for seeking GLP-1 medication, the report did not include additional medical details or dosage information. The Fox News article also did not cite any specific accounts or names of critics, focusing instead on Metz’s general response to ongoing online commentary.
It is unclear from the report whether Metz’s GLP-1 use is an ongoing therapy plan or how her treatment has changed over time. Further reporting or follow-up statements from Metz or her representatives would be needed to clarify the current status of her medical care, beyond her description of beginning GLP-1 treatment after her father’s death and her broader stance toward online criticism.
Why It Matters
- Metz’s remarks highlight how public figures’ health choices can become recurring online targets, affecting how audiences interpret discussions of medical treatment.
- The comments add a personal account to the ongoing culture debate over GLP-1 drugs, stigma, and the difference between lifestyle change and clinical treatment.
- By citing a family loss tied to obesity complications, Metz’s statements emphasize that health decisions can be influenced by real-world consequences that others may not see.
- The focus on persistent online commentary underscores the potential social cost of scrutinizing bodies in public spaces, especially for women in entertainment.
- The lack of medical specifics beyond beginning GLP-1 treatment suggests that viewers may still have to rely on general statements rather than detailed clinical information.
Key Facts
- Chrissy Metz said online weight-loss critics are “always going to have something to say,” according to a Fox News report dated Aug. 16, 2026.
- Metz discussed the role her family history played in how she approached weight and medical treatment.
- Fox News reported that Metz said her father died from obesity-related complications.
- Metz told Fox News she started GLP-1 medication after her father’s death, as part of her own health decisions.
- The interview focused on Metz’s response to internet scrutiny rather than on specific critics or accounts.